AGORACOM-AC's Recent Posts
Title ▼ Rating Company Posted on
ZeU Announces Warrant Extension ZeU Technologies Jun 06, 2023 09:23AM
Xali Gold Trading Halt Xali Gold Corp. Aug 06, 2024 07:00AM
Xali Gold Options High Sulphidation Gold Project in Central Peru Xali Gold Corp. Sep 05, 2024 07:00AM
Xali Gold Enters Agreement for Mining in Historic Underground Workings, Exploration and Reducing Debt at El Oro Mexico Xali Gold Corp. Jul 22, 2024 07:00AM
Xali Gold Advances on Two Fronts at El Oro Xali Gold Corp. Aug 28, 2024 07:00AM
With World Record In Sight, HPQ Silicon Groundbreaking Advancement in Li-Ion Battery Tech Unleashes $130B Silicon Anode Market Potential 7 HPQ Silicon Inc. May 27, 2024 11:24AM
With Two New Behavioral Health Customers, SOBRsafe has Now Secured 20 New Accounts in 2024 SOBR Safe Inc. May 14, 2024 08:00AM
With New Four-Facility Customer, SOBRsafe Enters Florida - a Key Behavioral Health Market SOBR Safe Inc. Apr 17, 2024 08:00AM
With $14M + In Contracts YTD Cloud DX Dominates Canada's Remote Patient Monitoring Market Cloud DX Inc. May 27, 2024 11:10AM
VOLUME ALERT: SOBRSafe (SOBR: NASDAQ) Up 9% On 65.2M Shares SOBR Safe Inc. Jun 27, 2024 04:00PM
Video: SOBRsafe CEO Recaps Debut Year, Gives Perspective on 2023 in Comprehensive Interview SOBR Safe Inc. Jan 13, 2023 08:00AM
Video Update: SOBRsafe CEO Dave Gandini Discusses Evolved Sales Focus and 2024 Strategy SOBR Safe Inc. Apr 16, 2024 09:00AM
Valeo Pharma to Webcast Live at Virtual Investor Conference March 9th Valeo Pharma Inc. Mar 06, 2023 08:35AM
VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2022 RESULTS CONFERENCE CALL / WEBCAST Valeo Pharma Inc. Jan 25, 2023 09:38AM
VALEO PHARMA TO HOST FIRST QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST Valeo Pharma Inc. Mar 09, 2023 07:00AM
Valeo Pharma sees record quarterly revenue with a triple-digit increase over 1Q 2022 Valeo Pharma Inc. Mar 17, 2023 11:40AM
VALEO PHARMA REPORTS RECORD QUARTERLY REVENUES FOR THE FIRST QUARTER 2023 Valeo Pharma Inc. Mar 15, 2023 05:00PM
VALEO PHARMA REPORTS RECORD QUARTERLY AND ANNUAL REVENUES FOR THE FOURTH QUARTER AND THE FISCAL YEAR 2022 Valeo Pharma Inc. Jan 30, 2023 05:03PM
VALEO PHARMA RAISES Q4 AND FULL YEAR 2022 REVENUE GUIDANCE Valeo Pharma Inc. Nov 15, 2022 07:00AM
VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ONSTRYV® IN QUEBEC Valeo Pharma Inc. Feb 07, 2023 07:00AM